Fresenius Medical Care (NYSE: FMS) — Company Overview, News & Financial Data
Fresenius Medical Care focuses on dialysis products and services, enhancing patient care across various countries for kidney failure.
Fresenius Medical Care
Fresenius Medical Care is a healthcare company specializing in dialysis products and clinical services for individuals affected by chronic kidney disease and end-stage renal disease. The organization provides outpatient hemodialysis and peritoneal dialysis treatments through a global network of dedicated medical centers. In addition to direct patient care, the enterprise manufactures and distributes kidney dialysis machines, dialyzers, peritoneal dialysis fluids, and specialized acute blood purification systems. Operating globally, the company supports nephrology professionals, hospitals, and home care patients across North America, Europe, Asia-Pacific, Latin America, and other international jurisdictions.
Snapshot
Operations
Products and/or services of Fresenius Medical Care
- Care Enablement: Development, manufacturing, and distribution of medical equipment and supplies for renal care, including advanced hemodialysis machines, dialyzers, bloodlines, peritoneal dialysis equipment, and specialized water treatment systems for clinical and home environments.
- Care Delivery Services: Provision of comprehensive outpatient dialysis care, in-center hemodialysis treatments, home dialysis training, and clinical management services for hundreds of thousands of patients suffering from chronic kidney failure across international healthcare clinic networks.
- Critical Care and Acute Therapies: Provision of continuous renal replacement therapy hardware, acute blood purification systems, therapeutic apheresis platforms, and extracorporeal organ support equipment for intensive care patients experiencing acute kidney injury or systemic illness.
- Home Dialysis Solutions: Provision of portable home hemodialysis machines, automated peritoneal dialysis cyclers, specialized dialysis fluids, and virtual training applications designed to facilitate home-based renal replacement therapy for chronic kidney failure patients.
- Digital Health Solutions: Provision of integrated nephrology software systems, connected health applications, therapy data management platforms, and remote patient monitoring software that streamline clinical workflows and facilitate data exchange between patients and care teams.
- Renal Pharmaceuticals and Value-Based Care: Supply of specialized renal pharmaceuticals, laboratory diagnostic testing, and value-based healthcare management models designed to coordinate whole-person care for kidney disease patients while optimizing clinical outcomes and healthcare costs.
Fresenius Medical Care executive team
- Martin FischerCFO & Member of the Management Board
- Jorg HaringMember of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director
- Joseph E. Turk Jr.CEO of Care Enablement & Member of Management Board
- Charles Hugh-JonesGlobal Chief Medical Officer & Member of Management Board
- Cassie McLeanCEO of Care Delivery & Member of Management Board
- Dominik HegerExecutive VP and Head of Investor Relations, Strategic Development & Communications
- Joachim WeithSenior Vice President of Corporate Communications & Governmental Affairs
- Gail-Suzanne BrownSenior Vice President of Research & Development
- Glenn SlaterSenior Vice President of Manufacturing and Supply Chain Operations
- Wolfgang KummerleSenior Vice President - Quality Management International
Latest news about Fresenius Medical Care
Recent announcements
What Fresenius Medical Care (FMS) has told the market, newest first.
- NEWS_HALT halt | FMSPrice sensitive
Dividend history
Dividends per share paid by Fresenius Medical Care , by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2025 | — | $0.8720 | — | $0.8720 |
| FY2024 | — | $0.8150 | — | $0.8150 |
| FY2023 | — | $0.6340 | — | $0.6340 |
| FY2022 | — | $0.6180 | — | $0.6180 |
| FY2021 | — | $0.7090 | — | $0.7090 |
Key financials
Reported results for Fresenius Medical Care , in EUR.
- Market cap
- 11.6B
- Revenue (TTM)
- 19.5B
- P/E ratio
- 12.6
- EPS (diluted, TTM)
- 1.7
- Dividend yield
- 4.0%
- Profit margin
- 4.2%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 19.6B | 1.8B | 978.4M | |
| 19.3B | 1.5B | 537.9M | |
| 19.5B | 1.4B | 499M | |
| 19.4B | 1.5B | 673.4M |